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Morimont P, Lambermont B, Ghuysen A, Gerard P, Kolh P,
Lancellotti P, Tchana-Sato V, Desaive T, D’Orio V. Effective ar-
terial elastance as an index of pulmonary vascular load. Am J Physiol
Heart Circ Physiol 294: H2736–H2742, 2008. First published April
18, 2008; doi:10.1152/ajpheart.00796.2007.—The aim of this study
was to test whether the simple ratio of right ventricular (RV) end-
systolic pressure (Pes) to stroke volume (SV), known as the effective
arterial elastance (Ea), provides a valid assessment of pulmonary
arterial load in case of pulmonary embolism- or endotoxin-induced
pulmonary hypertension. Ventricular pressure-volume (PV) data (ob-
tained with conductance catheters) and invasive pulmonary arterial
pressure and flow waveforms were simultaneously recorded in two
groups of six pure Pietran pigs, submitted either to pulmonary embo-
lism (group A) or endotoxic shock (group B). Measurements were
obtained at baseline and each 30 min after injection of autologous
blood clots (0.3 g/kg) in the superior vena cava in group A and after
endotoxin infusion in group B. Two methods of calculation of pul-
monary arterial load were compared. On one hand, Ea provided by
using three-element windkessel model (WK) of the pulmonary arterial
system [Ea(WK)] was referred to as standard computation. On the
other hand, similar to the systemic circulation, Ea was assessed as the
ratio of RV Pes to SV [Ea(PV)  Pes/SV]. In both groups, although
the correlation between Ea(PV) and Ea(WK) was excellent over a
broad range of altered conditions, Ea(PV) systematically overesti-
mated Ea(WK). This offset disappeared when left atrial pressure (Pla)
was incorporated into Ea [Ea  (PV)  (Pes  Pla)/SV]. Thus Ea 
(PV), defined as the ratio of RV Pes minus Pla to SV, provides a
convenient, useful, and simple method to assess the pulmonary
arterial load and its impact on the RV function.
hemodynamics; pulmonary hypertension; right ventricle; ventriculo-
arterial coupling
IN CURRENT CLINICAL practice, pulmonary arterial load [or right
ventricular (RV) afterload] is usually expressed as the mean
pulmonary vascular resistance, computed as the ratio of the
pressure drop through the pulmonary circulation [difference
between mean pulmonary arterial pressure (PAPmean) and left
atrial pressure (Pla)] to the mean pulmonary blood flow [car-
diac output (CO)]. Such an evaluation ignores the pulsatile
nature of both pressure and flow. Although oscillatory compo-
nents of the pulmonary arterial load are low, and mean resis-
tance may be a valuable index of the pulmonary vascular load,
the pulsatile nature of the load may be prominent in numerous
pathological situations. Wave reflections play an important role
and should be taken into account in pulmonary hypertension
resulting from several pathological conditions, like pulmonary
embolism and septic shock (1, 2, 5, 14). In this way, the
pulmonary arterial impedance spectrum, which is defined in
the frequency domain, provides a more precise and complete
description of the pulmonary vascular load (12, 17). However,
because of its complexity, this approach is difficult to use in
clinical practice and to link with data obtained in the time
domain. Sunagawa et al. introduced the concept of the effective
arterial elastance (Ea), defined as a steady-state arterial param-
eter that incorporates the principal elements of the windkessel
model of the pulmonary vascular bed (24, 25). According to
this concept, Ea is computed by combining the pulmonary
vascular compliance, the characteristic impedance, and the
resistance of the main pulmonary vessels, as well as the
pulmonary peripheral resistance. An alternative method con-
sists in assessing Ea by the steady-state ratio of end-systolic
pressure to stroke volume (Pes/SV). This ratio can be simply
obtained from steady-state ventricular pressure-volume (PV)
measurements, while the pulmonary impedance spectrum or
the windkessel parameters require simultaneous pulmonary
arterial flow and pressure waveform acquisition. Moreover, the
ratio of end-systolic ventricular elastance to Ea, obtained from
PV relations, characterizes the ventriculo-arterial interaction.
In the systemic circulation, both normal and hypertensive
human subjects show good agreement between Ea computed
using left ventricular PV loop and Ea calculated from wind-
kessel model parameter value recorded in the aorta (10). In the
pulmonary circulation, it remains unknown whether or not
Ea(PV) can be used as a substitute of Ea(WK) [WK denotes Ea
derivation from windkessel model]. Therefore, the purpose of
the present study was to assess the validity of Ea(PV) derived
from steady-state RV PV data in experimental animals insulted
with endotoxin or submitted to clot embolism.
METHODS
All experimental procedures and protocols used in this investiga-
tion were reviewed and approved by the ethical committee of the
Medical Faculty of the University of Liege and conformed to the
Guide for the Care and Use of Laboratory Animals published by
the US National Institutes of Health (NIH publication no. 85-23, revised
1996). Experiments were performed on two groups of six healthy pure
Pietran pigs of either sex, weighing from 16 to 28 kg. The animals
were premedicated with intramuscular administration of ketamine (20
mg/kg) and diazepam (1 mg/kg). Anesthesia was then induced and
maintained by a continuous infusion of sufentanil (0.5 g kg1 h1)
and pentobarbital (5 mg kg1 h1). Spontaneous movements were
prevented by pancuronium bromide (0.2 mg kg1 h1). After endo-
tracheal intubation via a cervical tracheostomy, the pigs were con-
nected to a volume-cycled ventilator (Evita 2, Drager, Lubeck, Ger-
many) set to deliver a tidal volume of 10 ml/kg at a respiratory rate of
20 breaths/min with an inspired O2 fraction of 0.4. End-tidal CO2
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measurements (Capnomac, Datex, Helsinki, Finland) were used to
monitor the adequacy of ventilation. Respiratory settings were ad-
justed to maintain end-tidal CO2 between 30 and 35 Torr. The
pulmonary trunk was exposed via a median sternotomy. A microma-
nometer-tipped catheter (Sentron pressure measuring catheter, Cordis,
Miami, FL) was inserted into the main pulmonary artery through a
stab wound in the RV outflow tract. A 14-mm-diameter perivascular
flow-probe (Transonic Systems, Ithaca, NY) was placed around the
main pulmonary artery 2 cm downstream from the pulmonary valve.
The micromanometer-tipped catheter was manipulated so that the pressure
sensor was finally positioned at the level of the flow probe. Pla was
measured with a micromanometer-tipped catheter inserted into the
cavity through the left atrial appendage. Systemic arterial blood
pressure was monitored via a micromanometer-tipped catheter in-
serted into the abdominal aorta through the left femoral artery. A 7-F,
12-electrode (8-mm interelectrode distance) conductance microma-
nometer-tipped catheter (CD Leycom, Zoetermeer, the Netherlands)
was inserted through the RV infundibulum into the RV and positioned
so that all electrodes were in the RV cavity. A 6-F Fogarty balloon
catheter (Baxter Healthcare, Oakland, CA) was advanced into the
inferior vena cava through a right femoral venotomy. Inflation of this
balloon produced a gradual preload reduction.
Experimental protocol. After surgical preparation, the animals
were allowed to stabilize for 30 min. Baseline hemodynamic record-
ing was performed, including PAPmean, pulmonary blood flow (Q˙ ),
Pla, mean arterial blood pressure, and heart rate (HR). In the first
group (group A), autologous blood clots (0.3 g/kg) were injected in
the superior vena cava immediately after baseline measurements. In
the second group (group B), the animals had an intravenous infusion
of 0.5 mg/kg of a freshly prepared endotoxin solution (lipopolysac-
charide from E. coli serotype 0127:B8, Sigma, St. Louis, MO) over 30
min at time 0.
Data collection. All analog signals were continuously digitalized
with an appropriate system (Codas, DataQ, Akron, OH). The pulmo-
nary pressure and flow waves were sampled at 200 Hz and stored.
Cardiac cycles were defined by R-wave detection provided by a
permanent recording of a one-lead electrocardiogram. Ten consecu-
tive cycles were recorded during apnea and were numerically aver-
aged to obtain representative diagrams of pressure and flow waves,
corresponding to specific experimental conditions. Simultaneously, 10
consecutive RV PV loops were recorded. The same measurements
were then repeated during transient occlusion of the inferior vena cava
using the Fogarty balloon.
Data analysis. We used a lumped parameter model, i.e., the
three-element windkessel model (WK3), to analyze the flow condi-
tions in the pulmonary circulation throughout the experimental pro-
tocol (Fig. 1). The 10 steady-state beats were analyzed under each
condition (baseline, each 30 min after pulmonary embolism in group
A or endotoxin infusion in group B), and the results were averaged.
Maximal and minimal pulmonary arterial pressure defined systolic
and diastolic pressures, respectively. Systolic ejection interval (ts) was
measured from the foot of the pulmonary arterial pressure wave to its
incisura, and the diastolic interval was td  T  ts, where T is the
cardiac length. Pairs of pressure and flow data for each beat were
analyzed, and the three elements of the model were simultaneously
calculated by using an original analytic procedure, as described
previously (12).
RV PV loops were obtained using the conductance catheter method
(3). Pes was the pressure at maximal ventricular elastance (Emax) for
a steady-state loop. Maximal RV elastance was determined as
{P(t)/[V(t)  Vo]}max, where P(t) and V(t) are instantaneous RV
pressure and volume, respectively; and Vo is the volume intercept
of the end-systolic PV relation obtained using the preload reduc-
tion method (3).
Ea definitions. An expression of the effective Ea with the three
parameters of the WK3 is given by (12, 21, 24):
EaWK RT/ts 1 etd/ (1)
where RT is the total pulmonary vascular resistance, i.e., the sum of
the characteristic resistance (R1) and the pulmonary arteriolar resis-
Fig. 1. Representation of the three-element wind-
kessel model (WK) with an example of computer
record used to obtain averaged pulmonary pressure
(top) and flow (bottom) waveforms from 10 con-
secutive systoles in a typical group A pig. R1,
characteristic vascular resistance; C, vascular com-
pliance; R2, peripheral vascular resistance.
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tance (R2); and  is the diastolic pressure decay time constant or the
product of R2 and the total capacitance (C), which represents the
compliant properties of the pulmonary arterial tree. The electrical
representation of the WK3 is displayed in Fig. 1. The three elements
of the model are calculated using an analytic procedure (12, 14).
Details of this analysis are provided in the APPENDIX.
Eq. 1 can be simplified as follows. If the  is long compared with
the td ( 		 td), then the denominator reduces to ts 





RT  PAPmean Pla/CO (3)
Therefore,
EaWK PAPmean Pla/CO T 
 PAPmean Pla/SV HR T  PAPmean Pla/SV
(4)
If PAPmean is further approximated by RV Pes, then
EaWK PAPmean Pla/SV  Pes Pla/SV Ea * PV (5)
If the downstream pressure can be neglected as in the systemic
circulation, then
EaWK Pes/SV EaPV (6)
Statistical analysis. For each group, we performed a linear regres-
sion between Ea(WK) and Ea(PV), and we completed the analysis
with a Bland-Altman test (Statistica version 7, StatSoft). Changes in
hemodynamics and WK3 parameters were evaluated by a repeated-
measures analysis of variance (Statistica version 7, StatSoft). Data are
expressed as means  SE.
RESULTS
Windkessel parameters and PV loop effects of arterial load
variations. The effects of induced pulmonary hypertension in
both groups on HR, CO, mean arterial pressure, PAPmean, Pla,
and right atrial pressure are shown in Table 1. In group A,
pulmonary embolism was responsible for several alterations in
the shape of pressure and flow waves, including early pressure
inflection, late systolic peak pressure, and sharper pulmonary
arterial flow waveform (Fig. 1). The corresponding PV loops
became oblong due to a rise in ejection pressure (Fig. 2, left).
In group B, administration of endotoxin induced a bulging of
PV loops (Fig. 2, right). These modifications were related to
both reduced arterial compliance and enhanced wave reflec-
tions. Clot embolism and infusion of endotoxin lead to signif-
icant changes in the windkessel parameters, as shown in Fig. 3.
In group A (Fig. 3, left), R1 did not change significantly;
however, there was a rapid rise in R2 and a fall in C after
pulmonary embolism. In group B (Fig. 3, right), both R1 and
R2 significantly increased following endotoxin insult, whereas
C progressively decreased after endotoxin insult.
Ea(PV) compared with Ea(WK). The time course of both
Ea(PV) and Ea(WK) in each group is shown in Fig. 4. In group
A, Ea(PV) and Ea(WK) increased rapidly after the first vena
cava injection of embols. In group B, both parameters progres-
sively increased after endotoxin infusion. In each group, the
pulmonary Ea calculated with the complex method [Ea(WK)]
and the simple method [Ea(PV)] displayed a parallel evolution.
Despite the varying vascular properties due to either pulmo-
nary embolism or endotoxin infusion, the ratio of ventricular
Pes to SV [Pes/SV  Ea(PV)] was remarkably similar to
Ea(WK) derived from the windkessel parameters using Eq. 1.
However, Ea(PV) was somewhat higher than Ea(WK). The
offset between Ea(PV) and Ea(WK) was significantly reduced
by using Ea  (PV) instead of Ea(PV) (Fig. 4). Indeed, incor-
porating Pla into Ea(PV), the mean difference between both
methods decreased from 0.24  0.07 to 0.11  0.08 mmHg/ml
(means  SD) in group A and from 0.29  0.11 to 0.08  0.1
mmHg/ml (means  SD) in group B (Fig. 5).
The linear relations were nearly identical in both groups and
given by Ea  (PV)  0.92 Ea(WK) 
 0.1 [r2  0.96, n  56,
SE of estimate (SEE)  0.1, P  0.0001] in group A, and
Ea  (PV)  0.88 Ea(WK) 
 0.19 (r2  0.97, n  56, SEE 
0.21, P  0.0001) in group B (Fig. 5). The limits of agreement
indicated that the differences between both methods did not
exceed 0.08 mmHg/ml in group A and 0.11 mmHg/ml in group
B for 95% of the cases (Fig. 5).
Ea(PV) and RT/T. As for the relation between Ea(PV) and
Ea(WK), there was a strong linear correlation between Ea(PV)
Table 1. Effects of induced pulmonary hypertension on heart
rate, cardiac output, systemic and pulmonary arterial
pressures, and left and right atrial pressures
HR,








T0 1044 5.10.2 829 113 71 72
PHT 1144 4.80.2 7612 233 62 204
P NS 0.05 NS 0.001 NS 0.001
Group B
T0 1142 4.80.9 7513 152 82 82
PHT 1243 4.31 608 252 62 222
P NS NS NS 0.001 NS 0.001
Values are means  SE. T0, baseline conditions; PHT, pulmonary hyper-
tension; HR, heart rate; CO, cardiac output; MAP, mean arterial pressure;
PAPmean, mean pulmonary arterial pressure; Pla, left atrial pressure; Pra, right
atrial pressure; NS, not significant.
Fig. 2. Example of right ventricular (RV) pres-
sure-volume (PV) loops in a group A pig (left)
before (thick lines) and after (thin lines) pulmo-
nary embolism, and in a group B pig (right)
before (thick lines) and after (thin lines) endo-
toxin infusion. Lines representing Ea  (Pes 
Pla)/SV, where Ea is arterial elastance, Pes is
end-systolic pressure, Pla is left atrial pressure,
and SV is stroke volume, are shown for each PV
loop (dotted lines).
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and RT/T: Ea(PV)  1.1 RT/T 
 0.27 (r2  0.96, P  0.0001,
n  58, SEE  0.032) in group A, and Ea(PV)  0.98 RT/T 

0.36 (r2  0.97, P  0.0001, n  56, SEE  0.059) in group
B. The bias was still reduced using Ea  (PV) instead of
Ea(PV): Ea  (PV)  1.04 RT/T 
 0.11 (r2  0.93, P 
0.0001, n  58, SEE  0.038) in group A, and Ea  (PV) 
0.95 RT/T 
 0.23 (r2  0.96, P  0.0001, n  56, SEE 
0.051) in group B. The low SEE obtained in each group
corresponded to a good agreement between both parameters
(Fig. 6).
DISCUSSION
In the present study, we tested whether or not pulmonary
vascular load could be assessed by the effective Ea determined
by the simple ratio of Pes to SV [Ea(PV)]. Our results demon-
strated that there was an excellent correlation between Ea(WK)
calculated from the windkessel model and Ea calculated as
Pes/SV over a wide range of loading conditions resulting from
either pulmonary embolism or endotoxin insult. However, the
effective Ea determined by the simple ratio of Pes to SV
consistently exceeded the elastance calculated from the wind-
kessel parameters. The offset between Ea(PV) and Ea(WK)
nearly vanished using Ea  (PV), which incorporates Pla,
instead of Ea(PV). This observation implies that, contrary to
what is observed in the systemic circulation, the effect of the
downstream pressure on the pulmonary circulation is not neg-
ligible. Sagawa et al. suggested incorporating the presence of
an effective downstream pressure into Ea (21). Nevertheless,
Pla is frequently ignored in the pulmonary circulation, and Ea
is calculated as the ratio of Pes to SV similarly to the systemic
circulation (4, 9, 18, 28).
The linear relations between Ea  (PV) and Ea(WK) were
nearly identical in both groups. These results are concordant
with those of Kelly et al. (10) in the systemic circulation, who
Fig. 3. Time course of WK parameters (R1,
R2, C) in groups A (left) and B (right). *P 
0.05 compared with baseline.
Fig. 4. Time course of Ea(WK), Ea  (PV),
and Ea(PV) in groups A (left) and B (right).
#P  0.05 compared with baseline.
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showed that Ea(PV) provides a useful method to assess arterial
load and its interaction with the human ventricle. These authors
suggested that Ea(PV) is a powerful tool to assess the effects of
increased pulsatile load caused by aging or hypertension on PV
loops. They also pointed out that mean arterial resistance often
underestimates the real effects of the load on cardiac perfor-
mance (10). Segers et al. (23) found that Ea(PV) underesti-
mated Ea(WK) provided by the four-element windkessel
model.
Our results demonstrated that Ea  (PV) can be used in place
of Ea(WK) in the pulmonary circulation. The correlation be-
tween Ea  (PV) and Ea(WK) was excellent in normal condi-
tions, as well as after pulmonary embolism or endotoxin
infusion, as shown by the Bland-Altman test in both groups. In
group A, Ea showed an asymptotic increase early after the
pulmonary embolism, in concordance with an acute loss of
compliance and a rapid rise of the total resistance offered by
the pulmonary vascular tree. In group B, Ea progressively
increased with an exponential trend associated with a progres-
sive decrease in compliance and a slow rise in the total
resistance of the pulmonary vasculature. Although experimen-
tal conditions were totally different, the linear correlations
between both methods in each group were nearly similar.
Our data showed that pulmonary embolism or endotoxin
insult led to a complex pulmonary vascular response involving
a dynamic, time-dependent interplay between R1, C, and R2.
Nevertheless, the correlation between both methods in each
group remained excellent over the range of important varia-
tions in the windkessel parameters.
The ratio of Emax on Ea (Emax/Ea) is superior to one in the
normal heart, suggesting that the ventricle operates close to the
optimal efficiency. Our laboratory previously showed that, in
heart failure due to pulmonary embolism and sepsis, the
decreased value of Emax/Ea was related to an impaired use of
energy by the failing heart (6, 13, 15). In combination with
Emax, Ea(PV) appears to be a simple way to characterize
ventriculo-arterial interaction (18, 26, 27). For the systemic
circulation, Segers et al. (23) suggested that Ea can be approx-
imated by RT/T only for high C values. For the pulmonary
circulation, our results evidenced significant correlation be-
tween both methods, as well as between Ea  (PV) and RT/T,
despite dramatic changes in pulmonary vascular compliance.
Our laboratory previously showed a concordant evolution be-
tween Emax/Ea and stroke work in pulmonary embolism or
septic shock (6, 13, 15). This could be explained by higher
basal pulmonary vascular compliance compared with the val-
ues obtained on the systemic circuit.
The determination of Ea as the simple ratio of Pes minus Pla
to SV to assess pulmonary vascular load is rapidly and easily
feasible in clinical settings. In contrast, Ea(WK) requires inva-
sive measurement of pulmonary flow and pressure waves,
which limits its potential use (8, 19).
Fig. 5. Top: correlation between Ea  (PV) and
Ea(WK): Ea  (PV)  0.92 Ea(WK) 
 0.1
[r2  0.96, n  56, SE of estimate (SEE) 
0.1, P  0.0001] in group A (left), and Ea 
(PV)  0.88 Ea(WK) 
 0.19 (r2  0.97, n 
56, SEE  0.21, P  0.0001) in group B
(right). Bottom: Bland-Altman test compares
Ea  (PV) and Ea(WK) in groups A (left) and
B (right). The solid line is the mean differ-
ence; the dashed lines represent mean differ-
ence 2 SD.
Fig. 6. Correlation between Ea  (PV) and
total pulmonary vascular resistance (RT)/
cardiac length (T) is given by the following
linear relations: Ea  (PV)  1.04  RT/T 

0.11 (r2  0.93, P  0.0001, n  58, SEE 
0.038) (group A; left), and Ea  (PV) 
0.95  RT/T 
 0.23 (r2  0.96, P  0.0001,
n  56, SEE  0.051) (group B; right).
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RV tolerance and adaptation to chronic or acute increase in
pulmonary vascular load may be a cornerstone in the prognosis
of patients suffering from pulmonary hypertension. Therefore,
evaluation of RV-pulmonary arterial coupling by using the
ratio of contractility, assessed by the slope of the end-systolic
PV relationship, to Ea seems essential to evaluate correctly the
facilitation of energy transfer from the RV into the pulmonary
circuit (11). However, determination of Emax requires preload
variation that is difficult to apply in clinical practice. It is the
reason why single-beat methods have been developed, but
unfortunately not yet validated for the RV. Therefore, further
studies should be encouraged (16, 22). As pathophysiological
RV conditions are often associated with valve insufficiencies,
SV was derived from pulmonary arterial flow divided by HR.
Some study limitations should be acknowledged. Ea(WK)
and Ea  (PV) were related through two assumptions (Eqs.
2–6). Diastolic time constant (  R2 C) is long relative to the
diastolic time period (td), and Pes is approximately equal to
PAPmean. Compared with the systemic vasculature, lower pul-
monary vasculature resistance is counterbalanced by higher
pulmonary vascular compliance in such a way that the first
assumption can be considered as valid in basal conditions. In
pulmonary hypertension, rise in R2 prevails on loss in C, so the
first assumption holds. Because of lower pulmonary arterial
pressure levels, discrepancy between Pes and PAPmean is more
important than in the systemic vascular tree. However, in pulmo-
nary hypertension, due to higher pulmonary arterial pressure
levels and enhanced wave reflections occurring during systole,
PAPmean tends to be nearer to Pes.
In summary, several recent studies highlighted the impor-
tance of abnormal pulsatile load effect in the mechanism of
right heart failure (1, 2, 7, 20). Several methods to assess
pulmonary vascular load have been proposed, but require a
complete acquisition of pulmonary arterial pressure and flow
waveforms. As a result, such methods are difficult to apply in
current clinical practice. In the present study, we suggest that
pulmonary arterial load can be simply assessed from the ratio
of RV Pes minus Pla to RV SV in the setting of pulmonary
hypertension. The downstream pressure plays an important
role in the pulmonary circulation and should be incorporated
into the pulmonary effective Ea.
APPENDIX: CALCULATION OF WK3 PARAMETERS
The relationship between pressure and flow in the electrical repre-








where Q˙ is pulmonary flow; P is pulmonary arterial pressure; and t0 is
the beginning of the cardiac cycle, defined as the R wave on the ECG.




















The multiple-regression technique estimates the constants ki to min-
imize the residual sum of squares (RSS), i.e., the sum of squared










R1, R2, and C values are then derived by solving Eq. A3.
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